Equities

Willow Biosciences Inc

Willow Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)0.08
  • Today's Change-0.005 / -5.88%
  • Shares traded136.21k
  • 1 Year change-38.46%
  • Beta1.0487
Data delayed at least 15 minutes, as of May 23 2024 19:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

  • Revenue in CAD (TTM)949.00k
  • Net income in CAD-10.62m
  • Incorporated--
  • Employees19.00
  • Location
    Willow Biosciences Inc202, 1201 5th Street SWCALGARY T2R 0Y6CanadaCAN
  • Phone+1 (403) 910-5140
  • Fax+1 (403) 669-4848
  • Websitehttps://www.willowbio.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Crescita Therapeutics Inc17.92m-2.34m9.21m78.00--0.5062--0.5142-0.1162-0.11620.89270.92850.69031.504.62---9.01-0.2457-11.40-0.305956.0363.41-13.06-0.35182.60--0.0594---25.521.05-330.39---1.58--
Khiron Life Sciences Corp16.14m-30.66m9.32m310.00--0.3205--0.5778-0.1674-0.16740.0850.12480.30781.333.9052,055.68-58.47---69.10--19.51---190.00--0.9133--0.0864--59.60---37.81------
Valeo Pharma Inc54.29m-28.43m9.40m100.00------0.1732-0.3255-0.32550.6249-0.47651.233.5312.39434,296.00-64.52-64.35-215.78-113.2221.3823.88-52.37-69.710.2974-1.333.51--94.3165.20-8.01--76.61--
XORTX Therapeutics Inc0.00-4.58m10.40m3.00--3.04-----1.93-1.930.001.170.00-------42.59-35.42-45.30-40.37------------0.0056------72.04--7.91--
Medicure Inc21.69m-921.00k10.44m25.00--0.52458.370.4811-0.0893-0.08932.011.910.74862.524.36867,760.00-3.19-13.42-4.43-18.2864.4861.87-4.25-27.381.55-19.840.0266---5.94-5.71-167.55---28.82--
Willow Biosciences Inc949.00k-10.62m10.85m19.00--6.99--11.43-0.0853-0.08530.00760.01220.105--3.1649,947.37-117.47---144.53-------1,118.76--1.29--0.5682--42.75--12.05------
CanadaBis Capital Inc20.91m3.27m12.46m--3.801.523.080.59580.02370.02370.15140.05920.97781.909.81--15.27-20.5527.30-54.8652.50--15.62-26.610.55097.880.4948--90.44--630.61--238.08--
Delivra Health Brands Inc11.39m-1.11m12.54m----3.3259.731.10-0.0044-0.00440.04230.0121.052.175.95---10.26-45.81-20.21-58.3456.2137.95-9.78-289.551.42-0.37890.346--20.3068.2697.37---56.72--
Data as of May 23 2024. Currency figures normalised to Willow Biosciences Inc's reporting currency: Canadian Dollar CAD

Institutional shareholders

0.19%Per cent of shares held by top holders
HolderShares% Held
FINAD GmbHas of 31 Mar 2022235.50k0.19%
Data from 29 Dec 2023 - 29 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.